Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Exosomes derived from mesenchymal stem cells inhibit neointimal hyperplasia by activating the Erk1/2 signalling pathway in rats

Fig. 3

MSC-Exo accelerated the proliferation and migration of EC. a Cell growth analysis of MSC-CM-treated EC; EC-CM-treated EC served as the negative control group. b Cell growth analysis of MSC-Exo-treated EC; CM-Exo-free-treated EC served as the negative control group. c Western blot analysis of the expression of induced cell cycle-related proteins. d Immunofluorescence analysis of the number of Ki67-positive EC (green) after MSC-Exo treatment (magnifications, × 400; scale, 200 μm). e Quantitative analysis of the proportion of Ki67-positive EC. f Cell scratch experiment analysis of the migration of EC treated with MSC-Exo. g Quantitative analysis of the migration ratio of the indicated EC. h Western blot analysis of the expression of induced cell migration-related proteins. *P < 0.05 and **P < 0.01. All figures represent the average of three sets of independent experiments

Back to article page